SC 13G/AAMENDMENTKPTICIK 0001503802

Karyopharm Therapeutics Inc.

Name: SEC EDGAR filing 0001636587-26-000084
Creator: Karyopharm Therapeutics Inc.
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G/A) filed September 25, 2026.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Open the filing on SEC.gov

New to the SC 13G/A? What it is and how to read one

Filing facts

Accession number: 0001636587-26-000084
Filer: Karyopharm Therapeutics Inc.
Ticker: KPTI
CIK: 0001503802
Form type: SC 13G/A
Form description: 5%+ passive stake
Filed at: September 25, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: September 25, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from Karyopharm Therapeutics Inc.

SC 13G/A5%+ passive stakeSep 25, 2026

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1503802/000163658726000084/0001636587-26-000084-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Karyopharm Therapeutics Inc. (0001503802) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001636587-26-000084.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.